🔎 Trials Near Me

Utama › Pendarahan Serebral › Pennsylvania

Kajian klinikal Pendarahan Serebral di Pennsylvania

7 kajian untuk Pendarahan Serebral sedang mencari peserta di lokasi di Pennsylvania.

Bandar di Pennsylvania

Teks kajian rasmi (Bahasa Inggeris)

CoMind Early Feasibility Study

  • University of Pennsylvania Hospital, Philadelphia
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06368648

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

  • Geisinger Medical Center, Danville
  • Hospital of the University of Pennsylvania, Philadelphia
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07260916

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

  • The Hospital of the University of Pennsylvania, Philadelphia
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT04916210

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

  • Temple University Hospital, Philadelphia
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07227246

Rapid Evacuation and Access of Cerebral Hemorrhage Trial

  • Penn State Milton S. Hershey Medical Center, Hershey
Mengambil peserta
Umur 18 hingga 70 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06870812

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  • Jefferson Abington Hospital, Abington
  • Penn State Hershey Medical Center, Hershey
  • Hospital of the University of Pennsylvania, Philadelphia
  • dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Mei 2026 · NCT03907046

Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes

  • Thomas Jefferson University Hospitals, Philadelphia
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2025 · NCT06632587

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.